Medicine Description rhumaquick 50 mg
rhumaquick 20 tablets 50 mg is a medication that contains diclofenac sodium, a non-steroidal anti-inflammatory drug (NSAID). It functions by inhibiting the activity of cyclooxygenase (COX), an enzyme crucial in the conversion of arachidonic acid to prostaglandins. Prostaglandins are lipid compounds that mediate inflammation, pain, and fever. By blocking COX, diclofenac reduces the synthesis of these inflammatory mediators, thereby alleviating pain and decreasing inflammation in various conditions. This mechanism allows rhumaquick to provide symptomatic relief in conditions characterized by inflammatory pain.
Indications and Uses of rhumaquick 20 tablets 50 mg
- Rheumatoid arthritis
- Osteoarthritis
- Acute pain conditions
- Ankylosing spondylitis
- Post-operative pain
- Gout attacks
- Musculoskeletal disorders
Side Effects of rhumaquick 20 tablets 50 mg
- Gastrointestinal disturbances (nausea, vomiting)
- Headaches
- Dizziness
- Rash and skin reactions
- Increased liver enzymes
- Renal impairment
- Cardiovascular events (with prolonged use)
Storage and Handling
Store rhumaquick 20 tablets 50 mg at room temperature, away from excessive moisture and heat. Keep out of reach of children and securely seal the container after each use.
Patient Advice and Precautions
Patients should be advised to take rhumaquick with food to minimize gastrointestinal discomfort. It is important to inform healthcare providers about any pre-existing kidney, liver, or cardiovascular conditions before starting this medication. Regular monitoring for liver function tests may be warranted during prolonged therapy. Patients should also be cautioned against alcohol consumption while on NSAIDs to reduce the risk of gastrointestinal complications.